OPKO Health, Inc. Gain (Loss) on Extinguishment of Debt
OPKO Health, Inc. (OPK) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2019-03-01
- OPKO Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2016-12-31 was -$284.00K.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for the quarter ending 2016-03-31 was $0.00.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was $0.00.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for fiscal 2017 was $0.00.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for fiscal 2016 was -$284.00K.
- OPKO Health, Inc. gain (loss) on extinguishment of debt for fiscal 2014 was $2.67M, a 174.49% increase from fiscal 2013.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 | |||
| 2016-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$284.00K derived: sum of 2 quarters · filed 2019-03-01 | -$284.00K derived: sum of 3 quarters · filed 2019-03-01 | -$284.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | $1.23M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $1.23M derived: sum of 3 quarters · filed 2019-01-29 | $1.26M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $1.23M derived: sum of 2 quarters · filed 2019-01-29 | $1.26M derived: sum of 3 quarters · filed 2019-01-29 | $943.00K 8-K · filed 2019-01-29 |
| 2015-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.26M derived: sum of 2 quarters · filed 2016-11-07 | $943.00K 10-Q · filed 2016-11-07 | $943.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$291.00K 10-Q · filed 2016-08-08 | -$291.00K derived: sum of 3 quarters · filed 2017-03-01 | -$291.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$321.00K 10-Q · filed 2016-05-09 | -$321.00K derived: sum of 2 quarters · filed 2017-03-01 | -$321.00K derived: sum of 3 quarters · filed 2017-03-01 | $2.35M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $2.67M derived: sum of 3 quarters · filed 2017-03-01 | $2.67M 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.67M derived: sum of 2 quarters · filed 2015-11-09 | $2.67M 10-Q · filed 2015-11-09 | $2.67M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $2.67M 10-Q · filed 2015-08-05 | $2.67M derived: sum of 3 quarters · filed 2016-02-29 | $3.64M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $972.00K derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $972.00K derived: sum of 2 quarters · filed 2016-02-29 | $972.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $972.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $972.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |